Tudor Investment Corp’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-8,671
| Closed | -$340K | – | 2252 |
|
2024
Q4 | $340K | Sell |
8,671
-28,016
| -76% | -$1.1M | ﹤0.01% | 1325 |
|
2024
Q3 | $1.44M | Buy |
36,687
+11,455
| +45% | +$451K | 0.01% | 894 |
|
2024
Q2 | $984K | Buy |
25,232
+75
| +0.3% | +$2.92K | 0.01% | 976 |
|
2024
Q1 | $1.08M | Sell |
25,157
-18,064
| -42% | -$778K | 0.01% | 860 |
|
2023
Q4 | $1.99M | Buy |
+43,221
| New | +$1.99M | 0.02% | 706 |
|
2023
Q2 | – | Sell |
-29,908
| Closed | -$1.07M | – | 2038 |
|
2023
Q1 | $1.07M | Buy |
+29,908
| New | +$1.07M | 0.02% | 879 |
|
2022
Q3 | – | Sell |
-20,336
| Closed | -$619K | – | 2042 |
|
2022
Q2 | $619K | Buy |
+20,336
| New | +$619K | 0.02% | 999 |
|